SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-028843
Filing Date
2021-02-04
Accepted
2021-02-04 16:19:37
Documents
4
Effectiveness Date
2021-02-04

Document Format Files

Seq Description Document Type Size
1 S-8 d47076ds8.htm S-8 49572
2 EX-5.1 d47076dex51.htm EX-5.1 7422
3 EX-23.1 d47076dex231.htm EX-23.1 1573
4 GRAPHIC g47076g0204074617639.jpg GRAPHIC 2533
  Complete submission text file 0001193125-21-028843.txt   63247
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-252733 | Film No.: 21591410
SIC: 2834 Pharmaceutical Preparations